Cardiac troponin I in patients with hematologic malignancies

Coronary Artery Disease

Volumn 8, Issue 8-9, 1997, Pages 537-541

  Missov, Emile ^a,b,e   Calzolari, Charles ^c   Davy, Jean Marc ^a   Leclercq, Florence ^a   Rossi, Michel ^a   Pau, Bernard ^d  

^a Department of Cardiology ^*  (France)

^b INSERM   (France)

^c SANOFI   (France)

^d CNRS   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Anthracyclines; Cardiac troponin I; Cardiotoxicity

Indexed keywords

ANTHRACYCLINE; CREATINE KINASE MB; TROPONIN I;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEMATOLOGIC DISEASE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TROPONIN I;

EID: 0030723076     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rhoden W, Hasleton P, Brooks N: Anthracyclines and the heart. Br Heart J 1993, 70:499-502.
2. Carrio I, Estorch M, Lopez-Pousa A: Assessing anthracycline cardiotoxicity in the 1990s. Eur J Nucl Med 1996, 23:359-364.
3. Watts RG: Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: evidence for enhanced toxicity with multiagent chemotherapy. Am J Hematol 1991, 36:217-218.
4. Schwartz RG, McKenzie MB, Alexander J, Sager P, D'Souza A, Manatunga A, et al.: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Am J Med 1987, 82:1109-1118.
5. Wilkinson JM, Grand RJA: Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978, 271:31-35.
6. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS: Cardiac troponin I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995, 41:1710-1715.
7. Larue C, Calzolari C, Bertinchant J-P, Leclercq F, Grolleau R, Pau B: Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993, 39:972-979.
8. Missov E, Calzolari C, Pau B: Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997 (in press).
9. Smith SC, Ladenson JH, Mason JW, Jaffe AS: Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997, 95:163-168.
10. Larue C, Defacque-Lacquement H, Calzolari C, Le Nguyen D, Pau B: New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides. Molec Immunol 1992, 9:271-278.
11. Jackson JA, Reeves JP, Muntz KH, Kruk D, Prough RA, Willerson JT, et al.: Evaluation of free radical effects and cathecolamine alterations in adriamycin cardiotoxicity. Am J Pathol 1984, 117:140-153.
12. Singal PK, Segstro RJ, Singh RP, Kutryk MJ: Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol 1985, 1:139-147.
13. Singal PK, Deally CM, Weinberg LE: Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 1987, 19:817-828.
14. Missov E, Calzolari C, Pau B: Increased levels of cardiac troponin I in cancer patients [abstract]. J Am Coll Cardiol 1996, 29:321A.